Drug recall · June 13, 2018
Valsartan Tablets USP recall
Why: Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Valsartan Tablets USP, 320 mg, 90 tablet, Rx Only, Manufactured by: Jubilant Generics Ltd. Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-363-90
- Lots / codes
Lot #: VR417065A, VR417066A, Exp 10/2019
- Quantity
- 2,328 bottles (Lot VR417065A) and 2,352 bottles (Lot VR417066A)
- Company
- Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
- Distribution
- IN, MI, MS, NC, NJ, NY and OH
- Initiated
- May 25, 2018 · Voluntary: Firm initiated
- Classified
- June 15, 2018
- Reported
- June 13, 2018
- Ended
- January 8, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Valsartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.